Join us.

We’re working to create a just society and preserve a healthy environment for future generations. Donate today to help.

Donate

Sunstein Watch: Randall Lutter on Loan, Says OMB — Yet WashPost Reports He’s Actively Involved

As reporters dug deeper on our post yesterday about the return of Randy Lutter, chief economist at the Food and Drug Administration (FDA) under the George W. Bush Administration, to “regulatory czar” Cass Sunstein’s office, OMB spokesman Tom Gavin worked to downplay the significance of Lutter’s reappearance. Gavin confirmed that Lutter was in fact ensconced in OIRA, as reported by Inside EPA this morning, but said he was merely “on detail” from the FDA as a career civil servant who would report up the chain of command to Sunstein. The implication, of course, is that Lutter would have little influence on policy.

How heartwarming that argument must have been for civil servants at OIRA and elsewhere. As my colleague Sid Shapiro and I argue in a forthcoming book (The People's Agents and the Battle to Protect the American Public, arriving in spring), civil servants are the backbone and future hope of good government. Precisely because they play such an important role, their policy positions from past lives deserve scrutiny. And Randy Lutter is not a typical civil servant. Rather, he rose through the ranks both at OIRA and within FDA, while advancing the most rigid iterations of cost-benefit analysis. In fact, he is so widely known that word of his return to OIRA was spread to outside advocates like me by agitated civil servants, who see his return as further evidence that that OIRA is going to continue business as usual from Bush II.

In addition to downgrading the value of a lead-poisoned child’s IQ point to $1,500 because we should not transfer “wealth” from parents to children by asking parents to pay for their poisoned kids’ medical treatment, Randy Lutter has argued, in a seminal paper written for the American Enterprise Institute with his right-wing colleagues Kip Viscusi and Robert Hahn, that stringent health and safety regulations make people worse off because they make electricity, health care, and other life essentials more expensive. Lost from these elaborate calculations is any recognition that when people get sick from pollution, their care and their diminished quality of life are worth a lot of money, not to mention the important consideration that such protections are required by statutes passed by Congress and are not up for the reconsideration Lutter and his colleagues strongly urge.

OIRA is a tiny office, with somewhere between 30 to 40 professional staff. Its professional economists wield potentially huge influence over important regulatory decisions.

Proof of Lutter's active participation in important policy debates was provided by a Washington Post story up today reporting that Lutter "is now probing whether a rule to cut sulfur dioxide emissions would cost coal-fired utilities too much."

To be sure, the final buck on how OIRA behaves stops with Cass Sunstein. Holding Mr. Sunstein and his two deputies, Michael Fitzpatrick (a political appointee) and Kevin Neyland (a career employee) responsible for these outcomes assumes that the public is even able to discover what happened at the staff level. At the moment, OIRA’s communications with other federal agencies over regulatory policy are shrouded in secrecy. Posting these documents on the Internet and running a more transparent process is the only way to lend legitimacy to the notion that senior staff like Randy Lutter returned to OIRA to support a protective policy agenda rather than to sabotage it.

Showing 2,821 results

Rena Steinzor | December 3, 2009

Sunstein Watch: Randall Lutter on Loan, Says OMB — Yet WashPost Reports He’s Actively Involved

As reporters dug deeper on our post yesterday about the return of Randy Lutter, chief economist at the Food and Drug Administration (FDA) under the George W. Bush Administration, to “regulatory czar” Cass Sunstein’s office, OMB spokesman Tom Gavin worked to downplay the significance of Lutter’s reappearance. Gavin confirmed that Lutter was in fact ensconced […]

Rena Steinzor | December 2, 2009

Sunstein Watch: Randall Lutter to OIRA?

For a number of days now, we’ve been hearing rumors that Cass Sunstein, President Obama’s “regulatory czar,” was on the verge of hiring conservative economist Randall Lutter to join him at the Office of Information and Regulatory Affairs (OIRA). Few personnel developments could be more discouraging to those hopeful that the Obama Administration will fulfill […]

Holly Doremus | December 2, 2009

NPDES Permits on Impaired Waterways

Cross-posted from Legal Planet. Precisely what the Clean Water Act requires of point sources that discharge to already-polluted waterways has long been a point of confusion. Now, according to Inside EPA, EPA may revise the rules it applies to new permits on impaired waterways. A rulemaking seems far from certain at this point — the […]

Matt Shudtz | December 1, 2009

FDA Needs More Time for its Report on BPA

Yesterday came and went with no announcement from the FDA on the safety of BPA in food packaging. The agency had created a self-imposed November 30 deadline for releasing a new finding, and in the intervening months, a number of new studies on the health effects of BPA have been released and FDA has brought […]

John Echeverria | November 30, 2009

The Florida Beach Case Comes to Supreme Court: A Badly Flawed Test Case for Property Rights Advocates

On Wednesday, the U.S. Supreme Court will hear oral argument in Stop the Beach Renourishment v. Florida Department of Environmental Protection. By the time they finish hearing from both sides, the justices may wonder whether this case was worth their time and effort. (My amicus brief on the case is here). Petitioner is a small […]

Sidney A. Shapiro | November 25, 2009

Toyota Cars and Automobile Regulation, Still Defective: Recall Could Miss a Million Faulty Cars. Congress Should Investigate.

This morning, Toyota Motor Corporation announced it intends to replace accelerator pedals on about 3.8 million recalled vehicles in the United States because the pedals can get stuck in a floor mat. But the recall could still leave more than a million faulty cars on the road. As I wrote earlier, there had been over […]

James Goodwin | November 25, 2009

OIRA Must Be Having a Doorbuster Sale of Its Own

Perhaps caught up in the spirit of the holiday shopping season, a large number of industry bargain hunters have been busy seeking great deals on regulatory relief at the White House's Office of Information and Regulatory Affairs (OIRA) in recent weeks. To be precise, the bureau hosted no fewer than 11 meetings with corporate interests […]

Yee Huang | November 24, 2009

Yes, Senator Cardin’s Chesapeake Bay Bill Is Grounded in Constitutional Law

On Monday, CPR Member Scholars and others sent a memorandum to Senator Ben Cardin that addressed the constitutionality of S. 1816, the Chesapeake Clean Water and Ecosystem Restoration Act of 2009. At a Senate Subcommittee on Water and Wildlife hearing earlier this month, one witness contested the key provisions of S. 1816, asserting that they […]

Ben Somberg | November 23, 2009

What We’ll Look For in the Obama Administration’s Forthcoming Executive Order on Regulatory Process

The Obama Administration is expected to issue revisions to Executive Order 12,866, which specifies how the White House Office of Management and Budget (OMB) supervises federal regulatory agencies as they develop regulations to protect health, safety, the environment, and more (see the full comments on the matter submitted by CPR's board members in March). CPR […]